Danaher (DHR)
(Delayed Data from NYSE)
$252.04 USD
+3.67 (1.48%)
Updated Sep 25, 2023 04:02 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$252.04 USD
+3.67 (1.48%)
Updated Sep 25, 2023 04:02 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Danaher (DHR) Stock Moves -0.3%: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $254.46, moving -0.3% from the previous trading session.
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $253.77, moving -0.58% from the previous trading session.
Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PIO
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $248.33, marking a -0.74% move from the previous day.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $256.99 in the latest trading session, marking a -1.48% move from the prior day.
Here's Why You Should Steer Clear of Danaher (DHR) Stock Now
by Zacks Equity Research
Lower demand for COVID-related products, raw material cost inflation and foreign currency headwinds weigh on Danaher's (DHR) operations.
Markel Group (MKL) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Markel Group (MKL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $265, marking a +0.31% move from the previous day.
Should You Invest in the Invesco Global Water ETF (PIO)?
by Zacks Equity Research
Sector ETF report for PIO
Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PHO
Should You Invest in the Invesco Water Resources ETF (PHO)?
by Zacks Equity Research
Sector ETF report for PHO
Danaher (DHR) to Acquire Abcam, Boost Life Sciences Unit
by Zacks Equity Research
Danaher (DHR) is set to acquire Abcam in a $5.7 billion deal, boosting its Life Sciences portfolio while solving some of the world's greatest healthcare challenges.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $255.53 in the latest trading session, marking a +0.78% move from the prior day.
Abbott (ABT) Gains in Core Diagnostics With FDA Nod for Alinity H
by Zacks Equity Research
Abbott's (ABT) Alinity h-series not only delivers technological innovation but also addresses the realistic challenges faced by modern healthcare systems.
Honeywell (HON) Beats on Q2 Earnings, Lifts 2023 Guidance
by Zacks Equity Research
Honeywell's (HON) Q2 results benefit from growth in commercial aerospace, process solutions and UOP business. The company improves its 2023 sales, segment margin and earnings guidance.
Danaher (DHR) Q2 Earnings Beat, Sales Decline 7.7% Y/Y
by Zacks Equity Research
Danaher's (DHR) Q2 earnings and revenues beat estimates. However, a decline in the sale of COVID-related products weigh on the top line.
Danaher (DHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Danaher (DHR) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 2.50% and 0.83%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $240.79, moving +1.27% from the previous trading session.
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $237.76, moving -1.15% from the previous trading session.
Will Low COVID-Testing Volumes Mar Danaher's (DHR) Q2 Earnings?
by Zacks Equity Research
Lower demand for COVID-19 testing, vaccine and therapeutics is expected to have hurt Danaher's (DHR) Q2 performance. Rising cost of sales might have hurt the bottom line.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $237.67, moving +1.36% from the previous trading session.
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $236.81 in the latest trading session, marking a -1.33% move from the prior day.
Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PIO
Should You Invest in the Invesco Global Water ETF (PIO)?
by Zacks Equity Research
Sector ETF report for PIO